• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form S-8 filed by Gaxos.ai Inc.

    6/21/24 5:21:35 PM ET
    $GXAI
    Computer Software: Prepackaged Software
    Technology
    Get the next $GXAI alert in real time by email
    S-8 1 ea0208129-s8_gaxosai.htm REGISTRATION STATEMENT

    As filed with the Securities and Exchange Commission on June 21, 2024

    Registration No. 333-            

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    FORM S-8

     

    REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933

     

    GAXOS.AI INC.

    (Exact name of registrant as specified in its charter)

     

    Delaware   87-3288897
    (State or other jurisdiction of
    incorporation or organization)
      (I.R.S. Employer
    Identification No.)
         

    101 Eisenhower Pkwy, Suite 300

    Roseland, NJ

      07068
    (Address of principal executive offices)   (Zip Code)

     

    Gaxos.ai Inc. 2022 Equity Incentive Plan

    (Full title of the plan)

     

    Vadim Mats
    Chief Executive Officer
    Gaxos.ai Inc.

    101 Eisenhower Pkwy, Suite 300, Roseland, NJ 07068

    (Name and address of agent for service)

     

    (973) 275-7428

    (Telephone number, including area code, of agent for service)

     

    With a copy to:

    Richard Friedman, Esq.

    Ashton Wiebe, Esq.

    Sheppard, Mullin, Richter & Hampton LLP

    30 Rockefeller Plaza

    New York, NY 10112-0015

    Phone: (212) 634-3031

    Fax: (212) 655-1729

     

    Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

     

    Large accelerated filer ☐   Accelerated filer ☐   Non-accelerated filer ☒
        Smaller reporting company ☒   Emerging growth company ☒

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐

     

     

     

     

     

     

    EXPLANATORY NOTE

     

    Pursuant to General Instruction E of Form S-8, Gaxos.ai Inc, a Delaware corporation (the “Registrant”), is filing this registration statement on Form S-8 (the “Registration Statement”) with the Securities and Exchange Commission (the “Commission”) to register 95,304 additional shares of common stock, par value $0.0001 per share (the “Common Stock”), available for issuance under the Registrant’s 2022 Equity Incentive Plan (the “2022 Plan”). The number of shares of Common Stock available for issuance under the 2022 Plan may be increased each January 1st of every calendar year starting on March 30, 2022 and ending on January 1, 2032 by an amount equal to the lesser of (a) 5.0% of the Company’s outstanding Common Stock (on an as-converted basis, which shall include Shares issuable upon the exercise or conversion of all outstanding securities or rights convertible into or exercisable for Shares, including without limitation, preferred stock, warrants and employee options to purchase any Shares) on the final day of the immediately preceding calendar year and; and (b) a lesser amount determined by the Company’s board of directors, provided that shares of Common Stock issued under the 2022 Plan with respect to an exempt award, as defined in the 2022 Plan, shall not count against such share limit (the “Evergreen Provision”).

     

    The Registrant previously filed with the Commission a registration statement on Form S-8 on April 21, 2023 (Registration No. 333-271383) (the “Prior Registration Statement”), registering shares of common stock issuable under the 2022 Plan. This Registration Statement relates to securities of the same class as those to which the Prior Registration Statement relates and is submitted in accordance with General Instruction E of Form S-8 regarding Registration of Additional Securities. Pursuant to General Instruction E of Form S-8, the contents of the Prior Registration Statement are incorporated herein by reference and made part of this Registration Statement, except for Items 3 and 8, which are being updated by this Registration Statement.

     

     

     

     

    PART II

     

    INFORMATION REQUIRED IN THE REGISTRATION STATEMENT

     

    ITEM 3. INCORPORATION OF DOCUMENTS BY REFERENCE.

     

    The following documents filed by the Company with the Securities and Exchange Commission (“SEC”) pursuant to the Securities Act and the Securities Exchange Act of 1934, as amended (the “Exchange Act”), are incorporated herein by reference:

     

      ● The Company’s Annual Report on Form 10-K for the year ended December 31, 2023 filed with the SEC on March 27, 2024;
         
      ● The Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2024 filed with the SEC on May 14, 2024;
         
      ● The Company’s Current Reports on Form 8-K filed with the SEC on January 10, 2024; January 10, 2024; February 28, 2024; March 11, 2024, March 13, 2024; March 15, 2024 and March 20, 2024 (except for any portions of such Current Reports on Form 8-K furnished pursuant to Item 2.02 and/or Item 7.01 thereof and any corresponding exhibits thereto not filed with the SEC);
         
      ● The Company’s definitive proxy statement on Schedule 14A for the Company’s special meeting of stockholders filed with the SEC on January 23, 2024 and amended on January 25, 2024;
         
      ● The description of the Company’s common stock contained in Exhibit 4.1 to its Annual Report on Form 10-K for the year ended December 31, 2023 (File No. 001-41620) filed with the SEC on March 27, 2024, under Section 12(b) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), including any amendments or reports filed for the purpose of updating such description; and
         
      ● All other reports and documents filed by the Company pursuant to Section 13(a), 13(c), 14 or 15(d) of the Exchange Act (other than Current Reports furnished under Item 2.02 or Item 7.01 of Form 8-K and exhibits furnished on such form that relate to such items) subsequent to the date of this Registration Statement and prior to the filing of a post-effective amendment to this Registration Statement that indicates that all securities offered hereby have been sold or that deregisters all securities then remaining unsold, shall be deemed to be incorporated by reference into this Registration Statement and to be a part hereof from the date of filing such reports and documents. Any statement contained in a document incorporated or deemed to be incorporated by reference herein shall be deemed to be modified or superseded for purposes of this Registration Statement to the extent that a statement herein or in any subsequently filed document that also is or is deemed to be incorporated by reference herein modifies or supersedes such statement. Any such statement so modified or superseded shall not constitute a part of this Registration Statement, except as so modified or superseded.

     

    ITEM 8. EXHIBITS.

     

    See the attached Exhibit Index on the page immediately following the signature pages hereto, which is incorporated herein by reference.

     

    II-1

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Act of 1933, as amended, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in Roseland, New Jersey, on the 21st day of June, 2024.

     

      GAXOS.AI INC.
         
      By: /s/ Vadim Mats
        Vadim Mats
        Chief Executive Officer (Principal Executive Officer)

     

    POWER OF ATTORNEY

     

    KNOW ALL MEN BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Vadim Mats as his or her true and lawful attorney-in-fact and agent, with full power of substitution and resubstitution, for him or her and in their name, place and stead, in any and all capacities, to sign any and all amendments (including post-effective amendments), and to file the same, with all exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorney-in-fact and agent, full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully to all intents and purposes as he might or could do in person, hereby ratifying and confirming all that said attorney-in-fact and agent, or his substitute or substitutes, may lawfully do or cause to be done by virtue hereof.

     

    Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the date indicated.

     

    Signature   Title   Date
             
    /s/ Vadim Mats   Chief Executive Officer (Principal Executive Officer)   June 21, 2024
    Vadim Mats        
             
    /s/ Steven Shorr   Chief Financial Officer   June 21, 2024
    Steven Shorr   (Principal Financial and Accounting Officer)    
             
    /s/ Adam Holzer   Director   June 21, 2024
    Adam Holzer        
             
    /s/ Alex Kisin   Director   June 21, 2024
    Alex Kisin        
             
    /s/ Scott Grayson   Director   June 21, 2024
    Scott Grayson        

     

    II-2

     

     

    EXHIBIT INDEX

     

    Exhibit
    Number
      Description
    4.1   Gaxos.ai Inc. 2022 Equity Incentive Plan (Incorporated by reference to Exhibit 10.3 to the Company’s Registration Statement on Form S-1/A filed with the SEC on February 8, 2023).
    5.1*   Opinion of Sheppard, Mullin, Richter & Hampton LLP
    23.1*   Consent of Salberg & Company PA
    23.2*   Consent of D. Brooks and Associates CPAs, P.A.
    23.3   Consent of Sheppard, Mullin, Richter & Hampton LLP (included in Exhibit 5.1)
    24.1   Power of Attorney (included on signature page)
    107*   Filing Fee Table

     

    *Filed herewith

     

     

    II-3

     
    Get the next $GXAI alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $GXAI

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $GXAI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Director Holzer Adam

    4 - GAXOS.AI INC. (0001895618) (Issuer)

    4/15/25 7:03:36 PM ET
    $GXAI
    Computer Software: Prepackaged Software
    Technology

    SEC Form 4 filed by Director Grayson Scott

    4 - GAXOS.AI INC. (0001895618) (Issuer)

    4/15/25 7:02:46 PM ET
    $GXAI
    Computer Software: Prepackaged Software
    Technology

    SEC Form 4 filed by Director Feldman Roman

    4 - GAXOS.AI INC. (0001895618) (Issuer)

    4/15/25 7:01:32 PM ET
    $GXAI
    Computer Software: Prepackaged Software
    Technology

    $GXAI
    SEC Filings

    View All

    Gaxos.ai Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - GAXOS.AI INC. (0001895618) (Filer)

    2/4/26 5:14:56 PM ET
    $GXAI
    Computer Software: Prepackaged Software
    Technology

    SEC Form 424B5 filed by Gaxos.ai Inc.

    424B5 - GAXOS.AI INC. (0001895618) (Filer)

    2/4/26 5:11:57 PM ET
    $GXAI
    Computer Software: Prepackaged Software
    Technology

    SEC Form 424B5 filed by Gaxos.ai Inc.

    424B5 - GAXOS.AI INC. (0001895618) (Filer)

    1/23/26 4:35:48 PM ET
    $GXAI
    Computer Software: Prepackaged Software
    Technology

    $GXAI
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Amazon AWS Funds Gaxos AI Sales Platform Development

    Caylent Named Development Partner to Lead AWS-Native Build Roseland, NJ, Feb. 03, 2026 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various high-growth sectors, today announced that Amazon Web Services ("AWS") has committed to fund the preliminary development of Gaxos Labs' innovative, AI-powered sales coaching platform, positioning Gaxos to compete in the multibillion- dollar sales technology market. The AWS-backed initiative, in collaboration with Caylent, an AWS premier partner, supports the development of a real-time, AI sales platform designed for enterprise-scale deployment, incorporating live call t

    2/3/26 8:12:00 AM ET
    $GXAI
    Computer Software: Prepackaged Software
    Technology

    Gaxos Enters Multibillion-Dollar Digital Faith Market with Launch of Bible Pray AI

    Roseland, NJ, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various high-growth sectors, today announced the official launch of Bible Pray AI, a personalized, AI-powered spiritual growth platform designed to help users deepen faith, strengthen daily devotion, and apply scripture for greater peace, clarity, and purpose. Bible Pray AI represents Gaxos' strategic expansion into the rapidly growing digital faith, mental wellness, and personal development economy, a sector supported by hundreds of millions of engaged global users seeking guided spiritual content, daily motivation, and community-base

    12/9/25 8:00:00 AM ET
    $GXAI
    Computer Software: Prepackaged Software
    Technology

    Gaxos to Participate in Upcoming WAWTech Conference on December 16th and 17th in Warsaw, Poland

    Roseland, NJ, Nov. 12, 2025 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various high-growth sectors, today announced its participation in the upcoming WAWTech Conference, taking place on December 16-17, 2025 in Warsaw, Poland. "We're thrilled to take part in this year's WAWTech Conference ," said Vadim Mats, CEO of Gaxos. "This event offers a tremendous opportunity to engage with technology leaders and innovators across Europe, exchange ideas, and build partnerships that accelerate the growth and adoption of Gaxos AI offerings." To meet with Gaxos at the conferences or for press inquiries, please email pre

    11/12/25 8:00:00 AM ET
    $GXAI
    Computer Software: Prepackaged Software
    Technology

    $GXAI
    Leadership Updates

    Live Leadership Updates

    View All

    Gaxos Health Expands Medical Advisory Board

    Roseland, NJ, April 25, 2024 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various sectors, today announced that Gaxos Health has expanded its Medical Advisory Board with the appointment of Dr. Eric Margolis and Dr. Jeff Pavell. "The addition of top medical talent to our Medical Advisory Board reflects our continued commitment to pursuing a best-in-class solution for Gaxos Health," said Vadim Mats, CEO of Gaxos.AI. "An advisory board of experts in their respective fields will allow to create a better product and advancing our mission of creating value for shareholders." Dr. Eric Margolis, M.D.  is a Board-Ce

    4/25/24 8:45:00 AM ET
    $GXAI
    Computer Software: Prepackaged Software
    Technology

    $GXAI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Gaxos.ai Inc.

    SC 13G - GAXOS.AI INC. (0001895618) (Subject)

    11/14/24 3:30:50 PM ET
    $GXAI
    Computer Software: Prepackaged Software
    Technology

    $GXAI
    Financials

    Live finance-specific insights

    View All

    Gaxos Acquires Rights to AI-enabled Technology from Top Biohacking App

    Roseland, NJ, March 13, 2024 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various sectors, today announced that it had acquired the rights to use certain AI-enabled technology from a top biohacking app, "Ultiself," in order to facilitate the development of its tech for Gaxos Health. The integration of Ultiself's proprietary technology into Gaxos Health's proposed product offering will enable enhanced customization and user experience aligning with modern-day consumer's demands for custom and efficient solutions. This move is expected to accelerate Gaxos Health's development and help solidify its positio

    3/13/24 8:30:00 AM ET
    $GXAI
    Computer Software: Prepackaged Software
    Technology